Lysophosphatidylcholine--biomarker of Metformin action: studied using UPLC/MS/MS.
暂无分享,去创建一个
Z. Xiong | Ning Li | Shuang Cai | Famei Li | Zhili Xiong | Taoguang Huo | Ning Li | Shuang Cai | Tao-guang Huo | Fa-mei Li
[1] J. Schölmerich,et al. Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes. , 2008, Biochimica et biophysica acta.
[2] R. Norman,et al. Metformin in polycystic ovary syndrome: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.
[3] R. DeFronzo,et al. Metformin: A review of its metabolic effects , 1998 .
[4] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[5] Eric Yang,et al. A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. , 2005, Rapid communications in mass spectrometry : RCM.
[6] J. Lindon,et al. NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.
[7] Samy I McFarlane,et al. Metformin: An Update , 2002, Annals of Internal Medicine.
[8] M. Reily,et al. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[9] I. Wilson,et al. A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. , 2005, Journal of pharmaceutical and biomedical analysis.
[10] I. Wilson,et al. Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.
[11] Elaine Holmes,et al. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. , 2005, Pharmacogenomics.
[12] D. Moher,et al. WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus. , 2015, The Cochrane database of systematic reviews.
[13] I. Wilson,et al. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. , 2007, Journal of proteome research.
[14] Qing Yang,et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[15] Guowang Xu,et al. Structural identification of human blood phospholipids using liquid chromatography/quadrupole-linear ion trap mass spectrometry , 2004 .
[16] Jianren Gu,et al. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. , 2005, Analytical chemistry.
[17] Ping Liu,et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. , 2006, Journal of proteome research.